Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents

Autologous hematopoietic stem cell transplantation (AHSCT) is established as a standard of care for diseases ranging from hematological malignancies to other neoplastic pathologies and severe immunological deficiencies. In April 1995, our group performed the first AHSCT in progressive multiple scler...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavriilaki, Maria, Sakellari, Ioanna, Gavriilaki, Eleni, Kimiskidis, Vasilios K., Anagnostopoulos, Achilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612973/
https://www.ncbi.nlm.nih.gov/pubmed/31341484
http://dx.doi.org/10.1155/2019/5840286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612973/
https://www.ncbi.nlm.nih.gov/pubmed/31341484
http://dx.doi.org/10.1155/2019/5840286

Ejemplares similares